1-2 of 2
Tim H. Ward
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C184: Validation of an ELISA for the determination of Rituximab pharmacokinetics in clinical trials subjects

Tim H. Ward, Grace Hampson, Jeff Cummings, Mike Bayne, Alison Tutt, Mark Cragg, Caroline Dive, Tim Illidge
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C184.
https://doi.org/10.1158/1535-7163.TARG-09-C184
Published: 10 December 2009
View article titled, Abstract C184: Validation of an ELISA for the determination of Rituximab pharmacokinetics in clinical trials subjects
Journal Articles

Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity

Jeffrey Cummings, Cassandra Hodgkinson, Rajesh Odedra, Patrizia Sini, Simon P. Heaton, Kirsten E. Mundt, Tim H. Ward, Robert W. Wilkinson, Jim Growcott, Andrew Hughes, Caroline Dive
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 455–463.
https://doi.org/10.1158/1535-7163.MCT-07-2136
Published: 17 March 2008
View article titled, Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
Open the PDF for Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity in another window